Owner Millennium Pharmaceuticals, Inc.

Inventors O'Keefe, Theresa; O'Brien, Siobhan; Jones, S Tarran; Newman, Walter; Horvath, Christopher; Larosa, Gregory J

Agent Davies Collison Cave

Pub. Number AU-B-2001233277

PCT Pub. Number WO01/57226

Priority 09/497,625 03.02.00 US

Filing date 2 February 2001

Wipo publication date 14 August 2001

Acceptance publication date 3 June 2004

C12N 015/62 Mutation or genetic engineering - DNA sequences coding for fusion proteins

A61P 031/18 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 019/02 Drugs for skeletal disorders

A61P 009/10 Drugs for disorders of the cardiovascular system

A61K 039/395 Medicinal preparations containing antigens or antibodies - Antibodies

C12N 005/10 Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 015/63 Mutation or genetic engineering - Introduction of foreign genetic material using vectors

C12N 015/13 Mutation or genetic engineering - Immunoglobulins

C07K 016/46 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

C07K 016/28 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61P 037/06 Drugs for immunological or allergic disorders